SEC Form D filing

TenNor Therapeutics (Suzhou) Ltd

Biotech · Series A · Regulation D 506(b) · Filed May 26, 2026

Offering amount: $14.7M
Exemption: Reg D 506(b)
Issuer state: Not disclosed
Filing date: May 26, 2026
Signature date: May 24, 2026
CIK: 0002136090

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: May 2026 Stage and month: Series A

Summary

Auto-generated

TenNor Therapeutics is a therapeutics company ($14.7M offering) with international team; biotech stage-a profile.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.